We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

235 hedge funds and large institutions have $3.22B invested in Array Biopharma Inc in 2018 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 83 increasing their positions, 62 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

230% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 20

46% more call options, than puts

Call options by funds: $27.3M | Put options by funds: $18.7M

34% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 62

26% more capital invested

Capital invested by funds: $2.56B → $3.22B (+$660M)

23% more funds holding

Funds holding: 191 → 235 (+44)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

Holders
235
Holders Change
+44
Holders Change %
+23.04%
% of All Funds
5.39%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
66
Increased
83
Reduced
62
Closed
20
Calls
$27.3M
Puts
$18.7M
Net Calls
+$8.62M
Net Calls Change
-$12.9M

Top Buyers

1
FCM
Farallon Capital Management
California
+$49.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$39.5M
3
American Century Companies
American Century Companies
Missouri
+$25.4M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$22.8M
5
PAMU
Pictet Asset Management (UK)
United Kingdom
+$19.6M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$84.3M
2
BI
BVF Inc
California
-$58M
3
ACA
Avoro Capital Advisors
New York
-$56.8M
4
O
OrbiMed
New York
-$43.6M
5
Morgan Stanley
Morgan Stanley
New York
-$33.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
151
Boston Advisors
Massachusetts
$732K +$719K +44,880 New
JP Morgan Chase
152
JP Morgan Chase
New York
$721K -$36.6K -2,284 -5%
CSS
153
Cubist Systematic Strategies
Connecticut
$701K +$666K +41,601 +3,126%
Teacher Retirement System of Texas
154
Teacher Retirement System of Texas
Texas
$676K -$341K -21,294 -34%
PA
155
Perceptive Advisors
New York
$655K +$643K +40,133 New
IA
156
IFG Advisory
Georgia
$622K -$102K -6,337 -14%
NSAM
157
North Star Asset Management
Wisconsin
$614K – – –
BPB
158
Badgley, Phelps & Bell
Washington
$563K -$48.1K -3,000 -8%
Public Employees Retirement Association of Colorado
159
Public Employees Retirement Association of Colorado
Colorado
$538K -$72.7K -4,541 -12%
Creative Planning
160
Creative Planning
Kansas
$520K +$154K +9,588 +43%
PPCM
161
Pillar Pacific Capital Management
California
$511K -$26.4K -1,650 -5%
DIA
162
Denver Investment Advisors
Colorado
$478K +$469K +29,289 New
RJFSA
163
Raymond James Financial Services Advisors
Florida
$463K +$208K +12,977 +84%
B
164
Bailard
California
$460K – – –
WG
165
Winton Group
United Kingdom
$448K +$440K +27,470 New
Citigroup
166
Citigroup
New York
$442K -$2.34M -145,855 -84%
HighTower Advisors
167
HighTower Advisors
Illinois
$438K +$223K +13,925 +107%
AB
168
Amalgamated Bank
New York
$433K -$8.71K -544 -2%
XK
169
Xact Kapitalforvaltning
Sweden
$421K +$117K +7,300 +40%
SCM
170
Silvant Capital Management
Georgia
$415K +$407K +25,426 New
FRM
171
Fox Run Management
Connecticut
$412K +$404K +25,228 New
Canada Life
172
Canada Life
Manitoba, Canada
$411K – – –
Commonwealth Equity Services
173
Commonwealth Equity Services
Massachusetts
$402K -$26.4K -1,650 -6%
AG
174
Aperio Group
California
$375K +$10.6K +661 +3%
Jane Street
175
Jane Street
New York
$369K -$757K -47,225 -68%
5 6
7
8 9

ARRY Hedge Fund Activity: Q1 2018 in Review

235 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q1 2018, worth a combined $3.22B — up 26% from $2.56B a quarter earlier.

Buyers outnumbered sellers: 66 funds opened new ARRY positions and 20 closed out — a net gain of 46 holders — while 83 added to existing stakes and 62 trimmed.

The largest buyer was Farallon Capital Management, opening a new position worth an estimated $49.6M. The largest seller was Point72 Asset Management, cutting an estimated $84.3M.

  • 235 institutional investors held Array Biopharma Inc (ARRY) as of Q1 2018, up from 191 in Q4 2017.
  • Funds reported $3.22B of Array Biopharma Inc stock for Q1 2018, up 26% quarter-over-quarter.
  • 66 funds opened new Array Biopharma Inc positions in Q1 2018 and 20 closed out, a net change of +46 holders.
  • The largest Array Biopharma Inc buyer in Q1 2018 was Farallon Capital Management, an estimated $49.6M added.
  • The largest Array Biopharma Inc seller in Q1 2018 was Point72 Asset Management, an estimated $84.3M sold.

Based on aggregated 13F filings for Q1 2018.